Northwestern University · Biomedical EngineeringLiver Cancer Therapy Innovations Unit
Dong-Hyun Kim · Evanston, Illinois
Research Focus
Dr. Dong-Hyun Kim's lab focuses on developing innovative treatments for liver cancer using a combination of immunotherapy and radioembolization techniques. The lab is dedicated to enhancing the effectiveness of immune checkpoint blockades by targeting them specifically to tumor sites, potentially improving patient outcomes. Their research aims to make therapies safer and more effective, with the ultimate goal of treating patients who would otherwise have limited options.
liver cancerimmune checkpoint blockaderadioembolizationtargeted therapytumor microenvironment
Research Aims
5AIM 01Investigate localized delivery of immune checkpoint inhibitors to tumors.
AIM 02Enhance therapeutic outcomes of radioembolization for liver cancer.
AIM 03Evaluate the safety profile of targeted immunotherapy using nanoparticles.
AIM 04Monitor treatment responses using imaging techniques.
AIM 05Explore the interactions between tumor microenvironment and immune therapies.
Skills the Lab Values
catheter techniquestumor imagingintra-arterial infusionflow cytometrynanoparticle synthesisimmunohistochemistry
Output against the department
Publications606top 11% of dept.64th of 595
this lab
most publishedleast published
Citations12ktop 28% of dept.166th of 595
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.